Prevalence of obese dogs in a population of dogs with cancer

Lisa P. Weeth, Andrea J Fascetti, Philip H Kass, Steven E. Suter, Aniel M. Santos, Sean J. Delaney

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective - To determine the body condition score (BCS) distribution for dogs examined at a teaching hospital and examine whether the BCS distribution for dogs with cancer differed significantly from the distribution for dogs without cancer. Sample population - 1,777 dogs with cancer and 12,893 dogs without cancer. Procedures - A retrospective prevalence case-control study was conducted that used medical records from 1999 to 2004. Information was collected on BCS (9-point system), age, breed, sex, neuter status, diagnosis, and corticosteroid administration. Body condition score at the time of examination for cancer (dogs with cancer) or first chronologic visit (dogs without cancer) was recorded. Logistic regression was used to compare BCS prevalence distributions between groups. Results - The overall prevalence of obese dogs (BCS ≥ 7/9) was 14.8% (2,169/14,670), and the overall prevalence of overweight dogs (BCS ≥ 6/ 9 to < 7/9) was 21.6% (3,174/14,670). There was a significant difference in the BCS distribution between dogs with and without cancer, with a slightly lower prevalence of being overweight and obese in dogs with cancer. The prevalence of obese and overweight dogs varied with specific cancer types when compared with the prevalence for dogs without cancer. Conclusions and clinical relevance - Differences in obesity prevalence among cancer types is suggestive of an incongruous effect of this variable on cancer expression or a differential effect of specific cancer types on weight status. Systematic use of BCSs will help elucidate the association between obesity and cancer development.

Original languageEnglish (US)
Pages (from-to)389-398
Number of pages10
JournalAmerican Journal of Veterinary Research
Volume68
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

Dogs
neoplasms
dogs
body condition
Population
Neoplasms
obesity
Obesity
adrenal cortex hormones
case-control studies
Teaching Hospitals
Medical Records
Case-Control Studies
Adrenal Cortex Hormones
Logistic Models
breeds
Weights and Measures
gender

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Prevalence of obese dogs in a population of dogs with cancer. / Weeth, Lisa P.; Fascetti, Andrea J; Kass, Philip H; Suter, Steven E.; Santos, Aniel M.; Delaney, Sean J.

In: American Journal of Veterinary Research, Vol. 68, No. 4, 04.2007, p. 389-398.

Research output: Contribution to journalArticle

Weeth, Lisa P. ; Fascetti, Andrea J ; Kass, Philip H ; Suter, Steven E. ; Santos, Aniel M. ; Delaney, Sean J. / Prevalence of obese dogs in a population of dogs with cancer. In: American Journal of Veterinary Research. 2007 ; Vol. 68, No. 4. pp. 389-398.
@article{ac4df5cc485547a8a846bff8bdda3f45,
title = "Prevalence of obese dogs in a population of dogs with cancer",
abstract = "Objective - To determine the body condition score (BCS) distribution for dogs examined at a teaching hospital and examine whether the BCS distribution for dogs with cancer differed significantly from the distribution for dogs without cancer. Sample population - 1,777 dogs with cancer and 12,893 dogs without cancer. Procedures - A retrospective prevalence case-control study was conducted that used medical records from 1999 to 2004. Information was collected on BCS (9-point system), age, breed, sex, neuter status, diagnosis, and corticosteroid administration. Body condition score at the time of examination for cancer (dogs with cancer) or first chronologic visit (dogs without cancer) was recorded. Logistic regression was used to compare BCS prevalence distributions between groups. Results - The overall prevalence of obese dogs (BCS ≥ 7/9) was 14.8{\%} (2,169/14,670), and the overall prevalence of overweight dogs (BCS ≥ 6/ 9 to < 7/9) was 21.6{\%} (3,174/14,670). There was a significant difference in the BCS distribution between dogs with and without cancer, with a slightly lower prevalence of being overweight and obese in dogs with cancer. The prevalence of obese and overweight dogs varied with specific cancer types when compared with the prevalence for dogs without cancer. Conclusions and clinical relevance - Differences in obesity prevalence among cancer types is suggestive of an incongruous effect of this variable on cancer expression or a differential effect of specific cancer types on weight status. Systematic use of BCSs will help elucidate the association between obesity and cancer development.",
author = "Weeth, {Lisa P.} and Fascetti, {Andrea J} and Kass, {Philip H} and Suter, {Steven E.} and Santos, {Aniel M.} and Delaney, {Sean J.}",
year = "2007",
month = "4",
doi = "10.2460/ajvr.68.4.389",
language = "English (US)",
volume = "68",
pages = "389--398",
journal = "American Journal of Veterinary Research",
issn = "0002-9645",
publisher = "American Veterinary Medical Association",
number = "4",

}

TY - JOUR

T1 - Prevalence of obese dogs in a population of dogs with cancer

AU - Weeth, Lisa P.

AU - Fascetti, Andrea J

AU - Kass, Philip H

AU - Suter, Steven E.

AU - Santos, Aniel M.

AU - Delaney, Sean J.

PY - 2007/4

Y1 - 2007/4

N2 - Objective - To determine the body condition score (BCS) distribution for dogs examined at a teaching hospital and examine whether the BCS distribution for dogs with cancer differed significantly from the distribution for dogs without cancer. Sample population - 1,777 dogs with cancer and 12,893 dogs without cancer. Procedures - A retrospective prevalence case-control study was conducted that used medical records from 1999 to 2004. Information was collected on BCS (9-point system), age, breed, sex, neuter status, diagnosis, and corticosteroid administration. Body condition score at the time of examination for cancer (dogs with cancer) or first chronologic visit (dogs without cancer) was recorded. Logistic regression was used to compare BCS prevalence distributions between groups. Results - The overall prevalence of obese dogs (BCS ≥ 7/9) was 14.8% (2,169/14,670), and the overall prevalence of overweight dogs (BCS ≥ 6/ 9 to < 7/9) was 21.6% (3,174/14,670). There was a significant difference in the BCS distribution between dogs with and without cancer, with a slightly lower prevalence of being overweight and obese in dogs with cancer. The prevalence of obese and overweight dogs varied with specific cancer types when compared with the prevalence for dogs without cancer. Conclusions and clinical relevance - Differences in obesity prevalence among cancer types is suggestive of an incongruous effect of this variable on cancer expression or a differential effect of specific cancer types on weight status. Systematic use of BCSs will help elucidate the association between obesity and cancer development.

AB - Objective - To determine the body condition score (BCS) distribution for dogs examined at a teaching hospital and examine whether the BCS distribution for dogs with cancer differed significantly from the distribution for dogs without cancer. Sample population - 1,777 dogs with cancer and 12,893 dogs without cancer. Procedures - A retrospective prevalence case-control study was conducted that used medical records from 1999 to 2004. Information was collected on BCS (9-point system), age, breed, sex, neuter status, diagnosis, and corticosteroid administration. Body condition score at the time of examination for cancer (dogs with cancer) or first chronologic visit (dogs without cancer) was recorded. Logistic regression was used to compare BCS prevalence distributions between groups. Results - The overall prevalence of obese dogs (BCS ≥ 7/9) was 14.8% (2,169/14,670), and the overall prevalence of overweight dogs (BCS ≥ 6/ 9 to < 7/9) was 21.6% (3,174/14,670). There was a significant difference in the BCS distribution between dogs with and without cancer, with a slightly lower prevalence of being overweight and obese in dogs with cancer. The prevalence of obese and overweight dogs varied with specific cancer types when compared with the prevalence for dogs without cancer. Conclusions and clinical relevance - Differences in obesity prevalence among cancer types is suggestive of an incongruous effect of this variable on cancer expression or a differential effect of specific cancer types on weight status. Systematic use of BCSs will help elucidate the association between obesity and cancer development.

UR - http://www.scopus.com/inward/record.url?scp=34247513466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247513466&partnerID=8YFLogxK

U2 - 10.2460/ajvr.68.4.389

DO - 10.2460/ajvr.68.4.389

M3 - Article

C2 - 17397294

AN - SCOPUS:34247513466

VL - 68

SP - 389

EP - 398

JO - American Journal of Veterinary Research

JF - American Journal of Veterinary Research

SN - 0002-9645

IS - 4

ER -